Skip to content

Clinical trials

Withdrawn Phase 1/2 Lymphoma, Non-Hodgkin trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 1/2 Status: Withdrawn Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20103
20142
20151
20161
20171
20191
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Alliance for Clinical Trials in Oncology1
Charite University, Berlin, Germany1
Gilead Sciences1
GlaxoSmithKline1
ImmunityBio, Inc.1
Juventas Cell Therapy Ltd.1
Kjeld Schmiegelow1
Mayo Clinic1
RedHill Biopharma Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin15
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma5
Lymphoma, Follicular5
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Mantle-Cell5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Burkitt Lymphoma4
Leukemia4
Lymphoma, B-Cell, Marginal Zone4

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.